​
​

Oncology Institute (TOI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Oncology Institute Revenue Highlights

Latest Revenue (Y)

$324.24M

Latest Revenue (Q)

$99.90M

Main Segment (Y)

Health Care, Patient Service

Oncology Institute Revenue by Period

Oncology Institute Revenue by Year

DateRevenueChange
2023-12-31$324.24M28.42%
2022-12-31$252.48M24.37%
2021-12-31$203.00M8.26%
2020-12-31$187.51M20.66%
2019-12-31$155.41M37.33%
2018-12-31$113.16M-

Oncology Institute generated $324.24M in revenue during NA 2023, up 28.42% compared to the previous quarter, and up 286.53% compared to the same period a year ago.

Oncology Institute Revenue by Quarter

DateRevenueChange
2024-09-30$99.90M1.34%
2024-06-30$98.58M4.13%
2024-03-31$94.67M10.35%
2023-12-31$85.79M4.57%
2023-09-30$82.03M2.26%
2023-06-30$80.22M5.29%
2023-03-31$76.19M6.68%
2022-12-31$71.42M9.92%
2022-09-30$64.98M6.66%
2022-06-30$60.92M10.44%
2022-03-31$55.16M5.46%
2021-12-31$52.30M0.06%
2021-09-30$52.27M4.88%
2021-06-30$49.84M2.60%
2021-03-31$48.58M-74.09%
2020-12-31$187.51M296.86%
2020-09-30$47.25M-0.06%
2020-06-30$47.28M7.40%
2020-03-31$44.02M17.83%
2018-12-31$37.36M-

Oncology Institute generated $99.90M in revenue during Q3 2024, up 1.34% compared to the previous quarter, and up 124.53% compared to the same period a year ago.

Oncology Institute Revenue Breakdown

Oncology Institute Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Dispensary Revenue$103.83M$79.34M$72.55M
Health Care, Patient Service$213.50M$166.78M$124.07M
Fee For Service$143.13M$105.44M$69.79M
Capitated Revenue$70.37M$61.34M$54.28M
Clinical Research Trials And Other Revenue$6.90M$6.36M$6.38M

Oncology Institute's latest annual revenue breakdown by segment (product or service), as of Dec 23: Health Care, Patient Service (39.70%), Fee For Service (26.62%), Dispensary Revenue (19.31%), Capitated Revenue (13.09%), and Clinical Research Trials And Other Revenue (1.28%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Clinical Research Trials And Other Revenue$1.94M$2.53M$3.62M$1.60M$1.68M$1.82M$1.51M$1.59M$1.43M
Health Care, Patient Service$49.75M$52.45M$109.81M$53.43M$50.27M$47.99M$44.63M$39.11M$35.06M
Fee For Service$34.94M$34.79M$72.79M$36.64M$33.70M$31.47M$28.27M$25.16M$20.54M
Dispensary Revenue$48.21M$39.68M$54.40M$25.20M$24.24M$21.61M$18.84M$20.22M$18.68M
Capitated Revenue$14.81M$17.67M$37.02M$16.79M$16.57M$16.53M$16.36M$13.94M$14.52M

Oncology Institute's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Health Care, Patient Service (33.24%), Dispensary Revenue (32.21%), Fee For Service (23.35%), Capitated Revenue (9.90%), and Clinical Research Trials And Other Revenue (1.30%).

Oncology Institute Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
UHSUniversal Health Services$14.28B$3.96B
SEMSelect Medical$6.66B$1.76B
EHCEncompass Health$4.80B$1.35B
AGLagilon health$4.32B$1.45B
ENSGEnsign Group$3.73B$1.08B
BKDBrookdale Senior Living$3.02B$784.17M
SGRYSurgery Partners$2.74B$770.40M
CANOCano Health$2.74B$788.07M
MDPediatrix Medical Group$1.99B$511.16M
ADUSAddus HomeCare$1.06B$289.79M
LFSTLifeStance Health Group$1.06B$312.72M
PNTGPennant Group$544.89M$168.75M
CCMConcord Medical Services$537.40M$34.94M
TOIOncology Institute$324.24M$99.90M
SNDASonida Senior Living$255.32M$74.75M
JYNTJoint$117.70M$30.20M

TOI Revenue FAQ

What is Oncology Institute’s yearly revenue?

Oncology Institute's yearly revenue for 2023 was $324.24M, representing an increase of 28.42% compared to 2022. The company's yearly revenue for 2022 was $252.48M, representing an increase of 24.37% compared to 2021. TOI's yearly revenue for 2021 was $203M, representing an increase of 8.26% compared to 2020.

What is Oncology Institute’s quarterly revenue?

Oncology Institute's quarterly revenue for Q3 2024 was $99.9M, a 1.34% increase from the previous quarter (Q2 2024), and a 21.78% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $98.58M, a 4.13% increase from the previous quarter (Q1 2024), and a 22.88% increase year-over-year (Q2 2023). TOI's quarterly revenue for Q1 2024 was $94.67M, a 10.35% increase from the previous quarter (Q4 2023), and a 24.25% increase year-over-year (Q1 2023).

What is Oncology Institute’s revenue growth rate?

Oncology Institute's revenue growth rate for the last 3 years (2021-2023) was 59.72%, and for the last 5 years (2019-2023) was 108.64%.

What are Oncology Institute’s revenue streams?

Oncology Institute's revenue streams in c 23 are Dispensary Revenue, Health Care, Patient Service, Fee For Service, Capitated Revenue, and Clinical Research Trials And Other Revenue. Dispensary Revenue generated $103.84M in revenue, accounting 19.31% of the company's total revenue, up 30.87% year-over-year. Health Care, Patient Service generated $213.5M in revenue, accounting 39.70% of the company's total revenue, up 28.01% year-over-year. Fee For Service generated $143.13M in revenue, accounting 26.62% of the company's total revenue, up 35.74% year-over-year. Capitated Revenue generated $70.37M in revenue, accounting 13.09% of the company's total revenue, up 14.72% year-over-year. Clinical Research Trials And Other Revenue generated $6.9M in revenue, accounting 1.28% of the company's total revenue, up 8.58% year-over-year.

What is Oncology Institute’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Oncology Institute was Health Care, Patient Service. This segment made a revenue of $213.5M, representing 39.70% of the company's total revenue.